Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -4.453% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CCC(=O)Nc1ccccc1Sc1ncnc2scc(-c3ccccc3)c12
b.) O=S1(=O)N=C(N/N=C/c2ccc(Br)o2)c2ccccc21
c.) CC1=NN(c2ccccc2)C(=O)/C1=C/c1cccs1
Answer: a. CCC(=O)Nc1ccccc1Sc1ncnc2scc(-c3ccccc3)c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1ccccc1Sc1ncnc2scc(-c3ccccc3)c12
CCC(=O)Nc1ccccc1Sc1ncnc2scc(-c3ccccc3)c12
N-[2-(5-phenylthieno[2,3-d]pyrimidin-4-yl)sulfanylphenyl]propanamide